Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study

Published:2020-11 Issue: Volume:88 Page:106873
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wu Ming,Ji Jing-jing,Zhong Li,Shao Zi-yun,Xie Qi-feng,Liu Zhe-ying,Wang Cong-lin,Su Lei,Feng Yong-wen,Liu Zhi-feng,Yao Yong-ming

Funder

National Natural Science Foundation of China

PLA)

Sanming Project of Medicine in Shenzhen

Shenzhen

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference29 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version);Jin;Mil. Med. Res.,2020

3. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017;Annane;Intensive Care Med.,2017

4. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

5. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China;Zhang;Clin. Immunol.,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing;International Immunopharmacology;2023-11

2. A study of factors affecting the length of hospital stay (LOS) of COVID-19 patients: A qualitative evidence in Iranian hospital;Journal of Education and Health Promotion;2023-11

3. Assessment of the environmental risk factors associated with traumatic dental injuries among WHO index-aged children and adolescents;Journal of Education and Health Promotion;2023-11

4. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression;Inflammopharmacology;2023-10-16

5. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms;Pneumonia;2023-09-25